AET EU 2025 x KACTUS
By Hannah Flaherty
Recent posts
KACTUS is excited to announce our participation in Antibody Engineering & Therapeutics Europe 2025, the premier European event advancing antibody discovery and engineering. Taking place from June 10–12, 2025, at the Congress Center in Basel, Switzerland, this conference brings together over 350 global leaders in antibody and protein engineering. With nine focused session themes and more than 30 exhibitors, it's an unparalleled platform for exploring the latest innovations in antibody therapeutics and fostering collaborations that drive the future of medicine.
What is the Antibody Engineering & Therapeutics conference?
The Antibody Engineering & Therapeutics (AET) conference is a premier annual event that brings together scientists, researchers, and industry professionals from biotechnology and pharmaceutical sectors to explore advancements in antibody-based therapeutics. This conference focuses on cutting-edge research, innovation, and development strategies in antibody engineering, bispecifics, antibody-drug conjugates (ADCs), immune-oncology, and more.
Event Overview
Venue: Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland
Dates: June 10th to 12th
-
Conference Day 1: Tuesday, June 10, 2025 – 7:00 AM to 6:45 PM
-
Conference Day 2: Wednesday, June 11, 2025 – 7:40 AM to 5:55 PM
-
Conference Day 3: Thursday, June 12, 2025 – 8:30 AM to 5:45 PM
Booth #28
Event Schedule
AET Europe offers a focused exploration of the latest tools, platforms, and strategies advancing antibody and protein therapeutic development. The three-day event features scientific sessions, poster presentations, and curated networking opportunities designed to spark collaboration and accelerate discovery. Explore the full AET agenda for a detailed look at what’s ahead.
Day 1: Tuesday, June 10, 2025
-
Registration, Coffee and Exhibit/Poster Viewing from 7:00 AM to 8:00 AM
-
Chairperson’s Remarks from 8:00 AM to 8:05 AM
-
Keynote Presentations from 8:05 AM to 9:35 AM
-
Networking Refreshment Break from 9:35 AM to 10:20 AM
-
Morning Scientific Presentations from 10:20 AM to 11:50 AM
-
Scientific Briefings from 11:20 AM to 12:20 PM
-
Registration, Coffee and Exhibit/Poster Viewing from 12:20 PM to 1:30 PM
-
Scientific Briefings from 1:30 PM to 2:00 PM
-
Afternoon Track Sessions from 2:00 PM to 5:45 PM
-
Networking Cocktail Reception and Exhibit/Poster Viewing from 5:45 PM to 6:45 PM
Day 2: Wednesday, June 11, 2025
-
Scientific Briefing from 7:40 AM to 8:10 AM
-
Registration, Coffee and Exhibit/Poster Viewing from 7:45 AM to 8:15 AM
-
Chairman’s Remarks from 8:15 AM to 8:20 AM
-
Morning Track Sessions from 8:20 AM to 9:50 AM
-
Networking Refreshment Break and Exhibit/Poster Viewing from 9:50 AM to 10:20 AM
-
Mid-Morning Track Presentations from 10:20 AM to 11:50 AM
-
Scientific Briefings from 12:20 PM to 1:10 PM
-
Networking Luncheon and Exhibit/Poster Viewing from 12:50 PM to 1:50 PM
-
Technology Talks in the Exhibit Hall from 1:10 PM to 1:30 PM
-
Afternoon Track Sessions from 1:50 PM to 5:55 PM
Day 3: Thursday, June 12, 2025
-
Registration and Coffee from 8:30 AM to 8:55 AM
-
Co-Chairs’ Remarks from 8:55 AM to 9:00 AM
-
Morning Track Sessions from 9:00 AM to 10:30 AM
-
Networking Refreshment Break from 10:30 AM to 11:00 AM
-
Mid-Morning Track Presentations from 11:00 AM to 12:30 PM
-
Scientific Briefing followed by Networking Luncheon from 12:30 PM to 1:30 PM
-
Chairman’s Remarks from 1:30 PM to 1:45 PM
-
Afternoon Presentations from 1:45 PM to 5:45 PM
-
Close of Conference at 5:45 PM
About KACTUS
KACTUS specializes in the development and production of high-quality, bioactive recombinant proteins and enzymes that support innovation across antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. With a catalog of over 2,500 recombinant proteins spanning diverse targets, species, tags, and formats, we are committed to meeting the evolving needs of scientists in translational research. Our focus on rigorous quality control and reliable supply ensures the consistency and performance that today’s therapeutic development demands.
Featured Products